Indian CRO taps ArisGlobal to up delivery capabilities
SIRO Clinpharm is in “a new area of growth” following the procurement of ArisGlobal’s LifeSphere Clinical platform, which has enabled the company to expand its business prospects, says CRO.
Archives for February 5, 2018
Cryoport supporting TiGenix sepsis clinical trial
The number of new clinical trials in the regenerative market space continues to grow, says Cryport, which will provide global logistics support for TiGenix’s upcoming Phase Ib/IIa study.
Charles River gains access to AstraZeneca’s lead discovery infrastructure
Charles River has been granted commercial access to AstraZeneca’s high-throughput screening (HTS) and compound management infrastructure, an investment that will help the company "deliver optimal benefit" to its customers, says executive.
Merck consumer health sale ‘at risk’ after Nestlé pull out
The sale of Merck KGaA’s consumer health unit is at risk after leading bidder Nestlé left the race for the business, sources have suggested.
Danish regulators slam Indian API maker for GMP failings
Kadam Exports Private has received a statement of non-compliance with GMP after the Danish Medicines Agency found manufacturing deficiencies at its facility in Gujarat.
INFOGRAPHIC
Fake meds on trial: EU report weighs up Member State punishment
Diverging penalties in EU Member States for the falsification of medicines raise concerns for organised crime, says Medicines for Europe.
Teva's volatility and Pfizer's plant upgrade a threat to rating, S&P
Standard and Poor's says it is considering lowering Teva’s rating as Momenta Pharmaceuticals’s generic version of Copaxone closes in on launch.